With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
Amidst potential staff shortages surrounding COVID-19, there’s never been a greater time to hypofractionate. Here’s a crowd-funded living document that outlines low-fraction options across disease sites. | RadOnc Tables 2020